Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Assay reproducibility of serum androgen measurements using liquid chromatography-tandem mass spectrometry.

Trabert B, Xu X, Falk RT, Guillemette C, Stanczyk FZ, McGlynn KA.

J Steroid Biochem Mol Biol. 2016 Jan;155(Pt A):56-62. doi: 10.1016/j.jsbmb.2015.09.032. Epub 2015 Sep 28.

PMID:
26416142
2.

Organophosphate insecticide use and cancer incidence among spouses of pesticide applicators in the Agricultural Health Study.

Lerro CC, Koutros S, Andreotti G, Friesen MC, Alavanja MC, Blair A, Hoppin JA, Sandler DP, Lubin JH, Ma X, Zhang Y, Beane Freeman LE.

Occup Environ Med. 2015 Oct;72(10):736-44. doi: 10.1136/oemed-2014-102798. Epub 2015 Jul 6.

PMID:
26150671
3.

The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.

Choi SY, Kim HJ, Cheong HS, Myung SC.

Korean J Urol. 2015 Jan;56(1):19-30. doi: 10.4111/kju.2015.56.1.19. Epub 2015 Jan 12.

4.

Polymorphisms of an innate immune gene, toll-like receptor 4, and aggressive prostate cancer risk: a systematic review and meta-analysis.

Weng PH, Huang YL, Page JH, Chen JH, Xu J, Koutros S, Berndt S, Chanock S, Yeager M, Witte JS, Eeles RA, Easton DF, Neal DE, Donovan J, Hamdy FC, Muir KR, Giles G, Severi G, Smith JR, Balistreri CR, Shui IM, Chen YC.

PLoS One. 2014 Oct 31;9(10):e110569. doi: 10.1371/journal.pone.0110569. eCollection 2014. Review.

5.

A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review).

Lacy JM, Kyprianou N.

Oncol Lett. 2014 Oct;8(4):1391-1396. Epub 2014 Jul 28.

6.

Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.

Black A, Pinsky PF, Grubb RL 3rd, Falk RT, Hsing AW, Chu L, Meyer T, Veenstra TD, Xu X, Yu K, Ziegler RG, Brinton LA, Hoover RN, Cook MB.

Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2374-82. doi: 10.1158/1055-9965.EPI-14-0700. Epub 2014 Sep 1.

7.

Clarifying the positive association between education and prostate cancer: a Monte Carlo simulation approach.

Pudrovska T, Anishkin A.

J Appl Gerontol. 2015 Apr;34(3):293-316. doi: 10.1177/0733464812473798. Epub 2013 Mar 21.

8.

Association between endogenous sex steroid hormones and inflammatory biomarkers in US men.

Tsilidis KK, Rohrmann S, McGlynn KA, Nyante SJ, Lopez DS, Bradwin G, Feinleib M, Joshu CE, Kanarek N, Nelson WG, Selvin E, Platz EA.

Andrology. 2013 Nov;1(6):919-28. doi: 10.1111/j.2047-2927.2013.00129.x. Epub 2013 Sep 30.

9.

Androgenetic alopecia at various ages and prostate cancer risk in an equal-access multiethnic case-control series of veterans.

Thomas JA, Antonelli JA, Banez LL, Hoyo C, Grant D, Demark-Wahnefried W, Platz EA, Gerber L, Shuler K, Eyoh E, Calloway E, Freedland SJ.

Cancer Causes Control. 2013 May;24(5):1045-52. doi: 10.1007/s10552-013-0182-4. Epub 2013 Mar 26.

11.
12.

Lifestyle and dietary factors in the prevention of lethal prostate cancer.

Wilson KM, Giovannucci EL, Mucci LA.

Asian J Androl. 2012 May;14(3):365-74. doi: 10.1038/aja.2011.142. Epub 2012 Apr 16. Review.

13.

Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Tsilidis KK, Travis RC, Appleby PN, Allen NE, Lindstrom S, Schumacher FR, Cox D, Hsing AW, Ma J, Severi G, Albanes D, Virtamo J, Boeing H, Bueno-de-Mesquita HB, Johansson M, Quirós JR, Riboli E, Siddiq A, Tjønneland A, Trichopoulos D, Tumino R, Gaziano JM, Giovannucci E, Hunter DJ, Kraft P, Stampfer MJ, Giles GG, Andriole GL, Berndt SI, Chanock SJ, Hayes RB, Key TJ.

Am J Epidemiol. 2012 May 1;175(9):926-35. doi: 10.1093/aje/kwr423. Epub 2012 Mar 29.

14.

Hormones and prostate carcinogenesis: Androgens and estrogens.

Bosland MC, Mahmoud AM.

J Carcinog. 2011;10:33. doi: 10.4103/1477-3163.90678. Epub 2011 Dec 8.

15.

Oral contraceptive use is associated with prostate cancer: an ecological study.

Margel D, Fleshner NE.

BMJ Open. 2011 Nov 14;1(2):e000311. doi: 10.1136/bmjopen-2011-000311. Print 2011.

16.

A diet, physical activity, and stress reduction intervention in men with rising prostate-specific antigen after treatment for prostate cancer.

Hébert JR, Hurley TG, Harmon BE, Heiney S, Hebert CJ, Steck SE.

Cancer Epidemiol. 2012 Apr;36(2):e128-36. doi: 10.1016/j.canep.2011.09.008. Epub 2011 Oct 20.

17.
18.

The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.

Sun T, Oh WK, Jacobus S, Regan M, Pomerantz M, Freedman ML, Lee GS, Kantoff PW.

Cancer Prev Res (Phila). 2011 Dec;4(12):2044-50. doi: 10.1158/1940-6207.CAPR-11-0283. Epub 2011 Sep 7.

19.

Dietary acrylamide and risk of prostate cancer.

Wilson KM, Giovannucci E, Stampfer MJ, Mucci LA.

Int J Cancer. 2012 Jul 15;131(2):479-87. doi: 10.1002/ijc.26383. Epub 2011 Sep 14.

20.

Non steroidal anti-inflammatory drug use and levels of oestrogens and androgens in men.

Gates MA, Araujo AB, Hall SA, Wittert GA, McKinlay JB.

Clin Endocrinol (Oxf). 2012 Feb;76(2):272-80. doi: 10.1111/j.1365-2265.2011.04188.x.

Items per page

Supplemental Content

Write to the Help Desk